SCHEMBL739810

SCHEMBL739810

COc1ccccc1C(C)(C)NC(=O)c1cc2c(NC(=O)c3cccs3)n[nH]c2s1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.47
KMT2A Q03164 8/20 0.44
MEN1 O00255 6/20 0.44
MAPT P10636 5/20 0.44
TP53 P04637 2/20 0.44
RAB9A P51151 4/20 0.42
POLB P06746 2/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
NPC1 O15118 3/20 0.41
GAA P10253 2/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
ELANE P08246 1/20 0.41
KLK7 P49862 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741622 0.87 RAB9A (0.41) KMT2AMEN1MAPTRAB9APOLB
SCHEMBL743308 0.87 AURKA (0.48) KMT2AMEN1MAPTRAB9ASMN1; SMN2
SCHEMBL741896 0.86 RAB9A (0.47) KMT2AMEN1MAPTTP53RAB9A
SCHEMBL739893 0.85 RAB9A (0.48) KMT2AMEN1MAPTTP53RAB9A
SCHEMBL5990181 0.85 HPGD (0.43) KMT2AMEN1MAPTTP53RAB9A
SCHEMBL741356 0.84 KMT2A (0.43) KMT2AMEN1MAPTRAB9APOLB
SCHEMBL2419373 0.83 HPGD (0.64) APLNRKMT2AMEN1MAPTTP53
SCHEMBL740045 0.82 AURKA (0.60)
SCHEMBL1779010 0.81 RXFP1 (0.48) APLNRKMT2AMEN1MAPTRAB9A
SCHEMBL741526 0.81 RAB9A (0.41) KMT2AMEN1MAPTRAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed